MYND Life Sciences Inc. (CNSX: MYND)
Health Care · Pharmaceuticals · CA
CA$—
— today · — 1Y
MYND Life Sciences Inc. (CNSX: MYND) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.77M.
trading between 0.01 and 0.14.
Tweenvest scores MYND Life Sciences Inc. across four factors: quality 16/100, value 71/100. Its strongest factor is value.
MYND price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.77M
- Revenue (TTM)
- $1.00
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.82
- 52-week high
- CA$0.14
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 74.55M
- Employees
- —
- Next earnings
- —
About MYND Life Sciences Inc.
Headquartered in Kelowna, Canada, MYND Life Sciences Inc. operates as a neuro-pharmaceutical enterprise focused on creating innovative therapies for depressive disorders. The company conducts scientific research and clinical trials across Canada and the United States to develop drugs derived from neuro-anti-inflammatory compounds. A significant part of their work involves the study and development of psilocin and psilocybin extracts, as well as their synthetic analogs.
- ISIN
- CA62857B1094
- Listed since
- May 27, 2021
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Instituto Rosenbusch S.A.BASE: ROSE | $4.07M | AR$145.00 | +3.20% |
| CordovaCann Corp.OTCPK: LVRL.F | $3.84M | $0.04 | +75.00% |
| PharmaTher Holdings Ltd.CNSX: PHRM | $3.83M | CA$0.06 | +9.09% |
| Vista Pharmaceuticals LimitedBSE: 524711 | $3.82M | Rs6.00 | -3.38% |
| Green Zebras Spolka AkcyjnaWSE: GRZ | $3.77M | zł9.30 | 0.00% |
| Murae Organisor LimitedBSE: 542724 | $3.76M | Rs— | — |
| Jupiter Neurosciences, Inc.NasdaqCM: JUNS | $3.76M | $2.96 | +3.68% |
| Bacil Pharma LimitedBSE: 524516 | $3.67M | Rs24.77 | -9.20% |
Figures last refreshed Oct 11, 2026.